Tumor-Derived FGF19

Completed

Conditions studied: Colorectal Cancer, Breast Cancer, Healthy

In brief

Identify and test thresholds, specificity and sensitivity for a potential cancer associated biomarker protein, FGF19, (and associated markers) for detection in human blood in the blood of breast and colorectal in cancer patients, and see if occurs at higher rates than healthy controls

Key facts

Study ID

NCT06068257

Run by

University of Central Florida

People needed

119

Starts

2023-06-06

Expected to finish

2026-07-01

Last updated by the study team

2026-07-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• The study will enroll adult persons with breast cancer or colorectal cancer or no cancer (healthy controls) who are able to do a fasting blood draw.
• (Pregnant women may choose to be in the study. The study procedures do not pose a risk to the safety of the unborn child or the woman.)

You may not qualify if…

• The study will not enroll persons who are unable or unwilling to provide informed consent.
• Adults unable to consent, individuals who are not yet adults, and prisoners will be excluded from this study.

Where it is running

• Burnett School Biomedical Sciences — Orlando, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.